Effects of partial volume correction on discrimination between very early Alzheimer's dementia and controls using brain perfusion SPECT

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 7, 2004, Pages 975-980

  Kanetaka, Hidekazu ^a,c   Matsuda, Hiroshi ^a   Asada, Takashi ^b   Ohnishi, Takashi ^a   Yamashita, Fumio ^b   Imabayashi, Etsuko ^a   Tanaka, Fumiko ^a   Nakano, Seigo ^a   Takasaki, Masaru ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

99mTc ECD; Alzheimer's disease; Partial volume correction; Regional cerebral blood flow; SPECT

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN SIZE; CINGULATE GYRUS; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL VOLUME CORRECTION; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; VOXEL BASED ANALYSIS; Z SCORE;

EID: 3142767464     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1491-3     Document Type: Article

References (29)

1. Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer's disease. Lancet 1994; 344:895.
2. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42: 85-94.
3. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, Nakano S, Takasaki M. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000; 41:1155-1162.
4. 123I]iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer's disease. Am J Psychiatry 2002; 159: 474-476.
5. Matsuda H, Kanetaka H, Ohnishi T, Asada T, Imabayashi E, Nakano S, Kato A, Tanaka F. Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction. Eur J Nucl Med Mol Imaging 2002; 29:1502-1505.
6. Sakamoto S, Matsuda H, Asada T, Ohnishi T, Nakano S, Kanetaka H, Takasaki MI. Apolipoprotein E genotype and early Alzheimer's disease: a longitudinal SPECT study. J Neuroimaging 2003; 13:113-123.
7. Matsuda H, Ohnishi T, Asada T, Li ZJ, Kanetaka H, Imabayashi E, Tanaka F, Nakano S. Correction for partial-volume effects on brain perfusion SPECT in healthy men. J Nucl Med 2003;44:1243-1252.
8. McKhann G, Drachman D, Folstein M, Katzman R, Prie D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
9. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992.
10. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572.
11. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
12. Muller-Gartner HW, Links JM, Prince JL, Bryan RN, McVeigh E, Leal JP, Davatzikos C, Frost JJ. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab 1992; 12:571-583.
13. Labbe C, Froment JC, Kennedy A, Ashburner J, Cinotti L. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging. Alzheimer Dis Assoc Disord 1996; 10:141-170.
14. Talairach J, Tourmoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical, 1988.
15. Ohnishi T, Matsuda H, Hashimoto T, Kunihiro T, Nishikawa M, Uema T, Sasaki M. Abnormal regional cerebral blood flow in childhood autism. Brain 2000; 123:1838-1844.
16. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36:1238-1248.
17. 15O positron emission tomography perfusion Z score. Neuroradiology 2000; 42:787-794.
18. Metz CE, Herman BA, Roe CA. Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets. Med Decis Making 1998; 18:110-121.
19. Jiang Y, Metz CE, Nishikawa RM. A receiver operating characteristic partial area index for highly sensitive diagnostic tests. Radiology 1996; 201:745-750.
20. Ibanez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, Rapoport SI, Schapiro MB, Horwitz B. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 1998; 50:1585-1593.
21. Chetelat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC. Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 2003; 60:1374-1377.
22. Berent S, Giordani B, Foster N, Minoshima S, Lajiness-O'Neill R, Koeppe R, Kuhl DE. Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. J Psychiatr Res 1999; 33:7-16.
23. Matsuda H, Kitayama N, Ohnishi T, Asada T, Nakano S, Sakamoto S, Imabayashi E, Katoh A. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J Nucl Med 2002; 43:304-311.
24. 99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake. Neuroimage 2002; 17:1193-1202.
25. Bartenstein P, Minoshima S, Hirsch C, Buch K, Willoch F, Mosch D, Schad D, Schwaiger M, Kurz A. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. J Nucl Med 1997; 38:1095-1101.
26. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82:239-256.
27. Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A, Albert MS. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998; 50:1563-1571.
28. 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med 2001; 42:548-557.
29. Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frolich L, Schonknecht P, Ito K, Mielke R, Kalbe E, Zundorf G, Delbeuck X, Pelati O, Anchisi D, Fazio F, Kerrouche N, Desgranges B, Eustache F, Beuthien-Baumann B, Menzel C, Schroder J, Kato T, Arahata Y, Henze M, Heiss WD. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002; 17:302-316.